From 1980 to 1990 we found progressive increases in workload (number of billable tests; 12.1% per year), staffing [number of full-time equivalents (FTEs); 5.6% per year], "revenues" (gross billings; 25.8% per year), and direct cost (12.9% per year) in the clinical chemistry laboratory of a large tertiary-care university medical center. The increase in direct cost was mainly attributable to an increase in salary cost (23.7% per year), whereas the impact of increasing "consumable" cost was relatively small (5.3% per year). In fact, after adjustment for inflation, the consumable cost was virtually unchanged or decreased during the 10-year study period. Initially, consumables represented about 60% of the direct cost, and the remaining 40% was for salaries. After 1982/83, however, the relative contribution of consumables and salaries to direct cost gradually reversed. Because the workload grew at a higher rate than staffing, the workload per FTE increased from 1980 to 1990 
have been widely discussed both at meetings and in publications of laboratory medicine (3) (4) (5) (6) (7) (8) . Undoubtedly, DRGS generated great interest in knowing the true cost and other economic aspects of laboratory testing. Yet, with one exception (9), we found that the information dealing with these issues was limited in terms of specific data. and laboratory indirect cost each represented about 15%, resulting in total reductions of gross revenue on the order of 40%. Thus, the "net revenue" approximated 60% of the gross billings in our institution during the study period. Also of interest is that, similar to practices in other hospitals in the US, the charges for laboratory tests for inpatients and outpatients were different (outpatients were charged 20% less for laboratory services than inpatients).
The workload was estimated by the sum of the number of tests actually performed in the laboratory and billed to the patient or third 4% to 5% per year, including annual base rate adjustment and anniversary raise (no merit raise applied).
As a measure of labor and personnel time, we, like LMIP, used the number of total laboratory VFEs, excluding pathologists.
Resufts
From 1980 to 1990, there was a steady increase in workload (on average, 12.1% per year), staffing (on average, 5.6% per year), and "revenue" (on average, 25.8% per year) (Figure 1 ). The increase in workload was associated with a comparable increase in direct cost: on average, 12.9% per year (Figure 1 ). Further analysis showed that the increment in direct cost was largely attributable to an increase in salary cost (on average, 23.7% per year), whereas the contribution of increase in consumable cost was relatively small (on average, 5.3% per year) (Figure 2, left) . In fact, the consumable cost during the 10-year study period and that the increase in direct cost was entirely attributable to an increasein salary cost (Figure 2, right) .
After adjustments with more-hospital-specific juliation indices, the gross revenue showed a total increase of only 50% to 100%, and the direct cost either remained unchanged or increased slightly(30%) during the 10-year study period (Table 3) . Based on adjustments with these inflation indices, the consumable cost decreased by as much as one-third,whereas the salary cost increased by -50% to 100% in 10 years (Table 3) .
Despite an increase in the number of FFEs, the workload grew at a higher rate than staffing, with a resulting increase in workload per employee (Figure 4) . These changes were paralleled by gradual increases in both revenue per FFE and salary per FTE in terms of either actual or CPI-corrected dollars ( Figure 5 ). By adjusting with more-hospital-specific inflation indices, however, both the revenue per FFE and salary per FFE showed a lesser or no increase during the 10-year study period ( Table 3 Several expanded and new services also became available in both hospital and outpatient facilities during the study period. These new services further increasedthe test volume and, in turn, reduced the relative contribution of our intrinsic growth to total growth.
Our likely intrinsic growth rate of 6% or less per year is only about one-quarter of the intrinsic growth reported for clinical chemistry, and only one-half of the intrinsic growth reported for overall clinical laboratory testingin the US in the 1970s (15) . Although DRGs may be partially responsible for this reduced growth in workload, we suspectthat the major factor is related to technological advancements in clinical chemistry. We propose that the very high (20% per year) intrinsic growth in the '70s (15) was largely due to widespread implementation of new automated analyzers and computer technology.
Once the high level of automation (providing quick turnaround times and high test output with small sample volumes at a low cost, often for 24 h a day) was achieved in most laboratories by the late '70s, the opportunity for further intrinsic growth became much more limited in the '80s and will likely remain relatively small in the coming years. In a recent report, Sarkozi In fact, we found remarkably gimilrn growth rates in workload and directcost over the 10-year study period.In inflationadjusteddollars, however, the total direct cost may have decreased and the direct cost per test definitely decreased during the 1980s (Table 3) . Initially 
